Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

811 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New insight into the biological activity of Salmo salar NK-lysin antimicrobial peptides.
Ortega L, Carrera C, Muñoz-Flores C, Salazar S, Villegas MF, Starck MF, Valenzuela A, Agurto N, Montesino R, Astuya A, Parra N, Pérez ET, Santibáñez N, Romero A, Ruíz P, Lamazares E, Reyes F, Sánchez O, Toledo JR, Acosta J. Ortega L, et al. Among authors: sanchez o. Front Immunol. 2024 Apr 9;15:1191966. doi: 10.3389/fimmu.2024.1191966. eCollection 2024. Front Immunol. 2024. PMID: 38655253 Free PMC article.
Acute phase determinant of post-thrombotic syndrome: A review of the literature.
Khider L, Planquette B, Smadja DM, Sanchez O, Rial C, Goudot G, Messas E, Mirault T, Gendron N. Khider L, et al. Among authors: sanchez o. Thromb Res. 2024 Apr 12;238:11-18. doi: 10.1016/j.thromres.2024.04.004. Online ahead of print. Thromb Res. 2024. PMID: 38643521 Free article. Review.
[Translation into French and republication of: "Home treatment for patients with cancer-associated venous thromboembolism"].
Sanchez O, Roy PM, Gaboreau Y, Schmidt J, Moustafa F, Benmaziane A, Élias A, Espitia O, Sevestre MA, Couturaud F, Mahé I; INNOVTE CAT Working Group. Sanchez O, et al. Rev Med Interne. 2024 Apr 16:S0248-8663(24)00096-1. doi: 10.1016/j.revmed.2024.04.003. Online ahead of print. Rev Med Interne. 2024. PMID: 38632029 Review. French.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
811 results